According to MarketsandMarkets™, the Active Pharmaceutical Ingredients (API) Market is projected to reach USD 199.42 billion by 2031 from USD 149.02 billion in 2026, at a CAGR of 6.0% during the ...

The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...

Curia Global, Inc. (Curia), a leading global contract, development and manufacturing organization (CDMO), today announced a strategic investment to expand its sterile API manufacturing capabilities ...

DUBLIN , Jan. 25, 2023 /PRNewswire/ -- The "Pharmaceutical API Manufacturing Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering. This report ...

DUBLIN, April 12, 2022 /PRNewswire/ -- The "Pharmaceutical API Manufacturing Global Market Report 2022: By Therapy, By API, By Drug" report has been added to ResearchAndMarkets.com's offering. The ...

Therapiva, a joint venture of Abu Dhabi-based Neopharma and India’s Laxai Life Sciences, says it has a GMP manufacturing plant in India. It will now add Dr. Reddy's entire API manufacturing business. ...

Italy's Olon, a maker of generic drugs and APIs, has acquired an API plant in India. (Eric Palmer) CDMO Olon is continuing its expansion binge with a deal to buy an API plant in India that supplies ...

Curia Global Inc (Curia), a global contract, development and manufacturing organisation (CDMO), has announced a strategic investment to expand its sterile active pharmaceutical ingredient (API) ...

Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...